PMID: 71541Oct 8, 1977

Haemoglobin A1: An indicator of the metabolic control of diabetic patients

Lancet
B GonenD L Horwitz

Abstract

The level of the minor glycosylated haemoglobins (HbA1) in ambulatory diabetic patients correlated closely with their physicians' ratings of the degree of control and their fasting plasma-glucose levels. In patients admitted to hospital for more detailed study, HbA1 correlated significantly with the mean fasting glucose, mean daily glucose, and highest daily glucose values. HbA1 measurement is a simple, rapid, and objective procedure to assess diabetic control and may serve both as a screening test for uncontrolled diabetes and as an indicator of the efficacy of various therapeutic regimens.

References

May 1, 1990·Diabetologia·F J TamesA J Bone
Feb 1, 1991·Journal of Behavioral Medicine·M P CareyA W Meisler
Mar 1, 1984·Biofeedback and Self-regulation·A M GrossP C Davidson
Jul 1, 1978·Diabetologia·G Gonen, A H Rubenstein
Jan 1, 1988·Acta diabetologica latina·M R AvernaA Notarbartolo
Apr 1, 1984·Acta diabetologica latina·J Ditzel, T Jensen
Jul 1, 1982·Indian Journal of Pediatrics·S C Kalhan
Jul 1, 2004·Indian Journal of Clinical Biochemistry : IJCB·Ishrat KareemV P Patil
Jan 1, 1979·Irish Journal of Medical Science·R Tattersall
Aug 1, 1980·Irish Journal of Medical Science·A L KennedyS L Campbell
Aug 1, 1978·Irish Journal of Medical Science·P S ParfreyF Lyons
Feb 1, 1982·Irish Journal of Medical Science·P D MayneR R O'Moore
Nov 1, 1986·Irish Journal of Medical Science·K Bulger, T J McKenna
Nov 16, 2011·International Journal of Clinical Pharmacy·Harith Kh Al-QazazFahad Saleem
Sep 23, 1980·Biochimica Et Biophysica Acta·E C AbrahamT H Huisman
Apr 16, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·V SaibeneG Pozza
Jul 1, 1980·Clinica Chimica Acta; International Journal of Clinical Chemistry·R C WorthK G Alberti
Oct 13, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·B J GouldJ G Cook
Sep 14, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·J W Van WerschW J Venekamp
Jan 1, 1987·Journal of Psychosomatic Research·C L Evans, I A Hughes
Jun 1, 1983·The Journal of Pediatrics·W V Tamborlane, R S Sherwin
Mar 19, 1999·Domestic Animal Endocrinology·M Hoenig, D C Ferguson
Feb 9, 1984·The New England Journal of Medicine·D M NathanJ D Goodson
Oct 11, 1990·The New England Journal of Medicine·M L LarsenE F Mogensen
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C E GuthrowJ W Baynes
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·Y IsraelR Arnon
Mar 1, 1985·The Journal of Genetic Psychology·A M GrossS Epstein
Jul 28, 2001·Diabetes Technology & Therapeutics·W T CefaluT King
May 20, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·D S LissJ Stephens
Nov 1, 1994·British Journal of Clinical Pharmacology·W D ByromJ R Bratty
Jun 1, 1980·Australian Paediatric Journal·B A DarlowD W Beaven
Feb 1, 1979·Australian and New Zealand Journal of Medicine·P C Bartley, T E Hambling

Related Concepts

HBA1
Hemoglobin Measurement
Eryhem
Novolin
Fasting
Specialty Type - Ambulatory
HBA1 gene
Metabolic Control
Diabetes Mellitus
Hemoglobin A

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.